Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II
Sign Up to like & getrecommendations! Published in 2018 at "JAMA Cardiology"
DOI: 10.1001/jamacardio.2018.3945
Abstract: Importance Black and Hispanic patients are less likely than white patients to use oral anticoagulants for atrial fibrillation. Little is known about racial/ethnic differences in use of direct-acting oral anticoagulants (DOACs) for atrial fibrillation. Objective… read more here.
Keywords: atrial fibrillation; fibrillation; use; oral anticoagulant ... See more keywords
Effect of Mailing Educational Material to Patients With Atrial Fibrillation and Their Clinicians on Use of Oral Anticoagulants
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.14321
Abstract: Key Points Question Does a single educational mailing to a patient with atrial fibrillation and their clinician increase the use of oral anticoagulants for stroke prevention? Findings This randomized clinical trial found no statistically significant… read more here.
Keywords: patients atrial; effect mailing; fibrillation; use oral ... See more keywords
Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants
Sign Up to like & getrecommendations! Published in 2023 at "JAMA Neurology"
DOI: 10.1001/jamaneurol.2022.4782
Abstract: Key Points Question Is the recent use of direct oral anticoagulants (confirmed ingestion within 48 hours) associated with increased risk of symptomatic intracranial hemorrhage following intravenous thrombolysis for ischemic stroke? Findings In this cohort study… read more here.
Keywords: intravenous thrombolysis; direct oral; patients ischemic; oral anticoagulants ... See more keywords
What Surgeons Should Know About Non–Vitamin K Oral Anticoagulants: A Review
Sign Up to like & getrecommendations! Published in 2018 at "JAMA Surgery"
DOI: 10.1001/jamasurg.2018.0374
Abstract: Importance Non–vitamin K oral anticoagulants (NOACs) are increasingly prescribed for patients to treat or prevent arterial or venous thromboembolism. The following 4 NOAC agents are approved by the US Food and Drug Administration for clinical… read more here.
Keywords: vitamin oral; noac agents; non vitamin; oral anticoagulants ... See more keywords
Bleeding complications in patients with gastrointestinal cancer and atrial fibrillation treated with oral anticoagulants
Sign Up to like & getrecommendations! Published in 2021 at "Cancer Medicine"
DOI: 10.1002/cam4.4012
Abstract: Direct oral anticoagulants (DOACs) may increase the risk of gastrointestinal (GI) bleeding in patients with atrial fibrillation (AF) and GI cancer compared with vitamin K antagonists (VKA). read more here.
Keywords: atrial fibrillation; oral anticoagulants; cancer; complications patients ... See more keywords
Novel oral anticoagulants (NOACs) in patients with atrial fibrillation (AF) and diabetes—Good or excellent?
Sign Up to like & getrecommendations! Published in 2017 at "Diabetes/Metabolism Research and Reviews"
DOI: 10.1002/dmrr.2893
Abstract: Atrial fibrillation (AF) is associated with an increased risk of stroke, systemic embolism, and death. In the last decade, novel oral anticoagulants (NOACs) have emerged and are nowadays a key player in the anticoagulant armamentarium… read more here.
Keywords: atrial fibrillation; oral anticoagulants; anticoagulants noacs; novel oral ... See more keywords
Comparison of effectiveness and safety between uninterrupted direct oral anticoagulants with and without switching to dabigatran in atrial fibrillation ablation
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Arrhythmia"
DOI: 10.1002/joa3.12333
Abstract: Recent studies have demonstrated the feasibility of uninterrupted direct oral anticoagulants (DOACs) with a temporary switch to dabigatran (“dabigatran bridge”) for atrial fibrillation (AF) ablation. We compared the effectiveness and safety between uninterrupted DOACs with… read more here.
Keywords: atrial fibrillation; effectiveness safety; oral anticoagulants; direct oral ... See more keywords
Use of direct oral anticoagulants in patients with atrial fibrillation in Scotland: Applying a coherent framework to drug utilisation studies
Sign Up to like & getrecommendations! Published in 2017 at "Pharmacoepidemiology and Drug Safety"
DOI: 10.1002/pds.4272
Abstract: To report the use of direct oral anticoagulants (DOACs) for stroke prevention in patients with atrial fibrillation in Scotland and advocate the standardisation of drug utilisation research methods. read more here.
Keywords: atrial fibrillation; oral anticoagulants; direct oral; drug ... See more keywords
Defining the duration of the dispensation of oral anticoagulants in administrative healthcare databases.
Sign Up to like & getrecommendations! Published in 2021 at "Pharmacoepidemiology and drug safety"
DOI: 10.1002/pds.5378
Abstract: PURPOSE In clinical practice, warfarin therapy requires frequent dose adjustments. In pharmacy claims, the days supplied value may not reflect the true duration of warfarin dispensation. This may affect the measures of association comparing the… read more here.
Keywords: dispensation; oral anticoagulants; duration; data driven ... See more keywords
Opportunities to optimise direct‐acting oral anticoagulants
Sign Up to like & getrecommendations! Published in 2020 at "Prescriber"
DOI: 10.1002/psb.1874
Abstract: The newer direct‐acting oral anticoagulants (DOACs) – apixaban, dabigatran, edoxaban, rivaroxaban – offer many advantages over older anticoagulants such as warfarin. However, in order to optimise their benefits, it is important that patients taking them… read more here.
Keywords: acting oral; oral anticoagulants; direct acting; opportunities optimise ... See more keywords
The Role of New Oral Anticoagulants (NOACs) in Cancer Patients.
Sign Up to like & getrecommendations! Published in 2017 at "Advances in experimental medicine and biology"
DOI: 10.1007/5584_2016_112
Abstract: New oral anticoagulants (NOACs) are likely to have a major impact in the next few years, changing clinical practice of anticoagulation therapy. Evidence on its efficacy and superiority to vitamin K antagonists (VKAs) in treating… read more here.
Keywords: oral anticoagulants; anticoagulants noacs; role new; cancer ... See more keywords